Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs SANOFI INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NEULAND LABS SANOFI INDIA NEULAND LABS/
SANOFI INDIA
 
P/E (TTM) x 25.4 31.0 82.0% View Chart
P/BV x 8.1 15.4 52.6% View Chart
Dividend Yield % 0.2 7.0 2.3%  

Financials

 NEULAND LABS   SANOFI INDIA
EQUITY SHARE DATA
    NEULAND LABS
Mar-23
SANOFI INDIA
Dec-22
NEULAND LABS/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs2,0047,939 25.2%   
Low Rs9665,454 17.7%   
Sales per share (Unadj.) Rs928.41,202.8 77.2%  
Earnings per share (Unadj.) Rs127.4269.5 47.3%  
Cash flow per share (Unadj.) Rs168.6287.7 58.6%  
Dividends per share (Unadj.) Rs10.00570.00 1.8%  
Avg Dividend yield %0.78.5 7.9%  
Book value per share (Unadj.) Rs774.8527.0 147.0%  
Shares outstanding (eoy) m12.8323.03 55.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.65.6 28.7%   
Avg P/E ratio x11.724.9 46.9%  
P/CF ratio (eoy) x8.823.3 37.8%  
Price / Book Value ratio x1.912.7 15.1%  
Dividend payout %7.8211.5 3.7%   
Avg Mkt Cap Rs m19,052154,224 12.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,0184,059 49.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m11,91227,701 43.0%  
Other income Rs m97730 13.4%   
Total revenues Rs m12,00928,431 42.2%   
Gross profit Rs m2,7188,349 32.6%  
Depreciation Rs m528419 126.0%   
Interest Rs m13117 768.6%   
Profit before tax Rs m2,1578,643 25.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5222,437 21.4%   
Profit after tax Rs m1,6356,206 26.3%  
Gross profit margin %22.830.1 75.7%  
Effective tax rate %24.228.2 85.9%   
Net profit margin %13.722.4 61.3%  
BALANCE SHEET DATA
Current assets Rs m7,60936,121 21.1%   
Current liabilities Rs m4,39027,425 16.0%   
Net working cap to sales %27.031.4 86.1%  
Current ratio x1.71.3 131.6%  
Inventory Days Days6117 5.5%  
Debtors Days Days1,10917 6,516.5%  
Net fixed assets Rs m8,18912,148 67.4%   
Share capital Rs m129230 56.1%   
"Free" reserves Rs m9,81211,906 82.4%   
Net worth Rs m9,94112,136 81.9%   
Long term debt Rs m7420-   
Total assets Rs m15,79848,279 32.7%  
Interest coverage x17.5509.4 3.4%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.80.6 131.4%   
Return on assets %11.212.9 86.7%  
Return on equity %16.451.1 32.2%  
Return on capital %21.471.4 30.0%  
Exports to sales %73.514.1 521.2%   
Imports to sales %15.114.6 103.9%   
Exports (fob) Rs m8,7503,904 224.1%   
Imports (cif) Rs m1,8044,037 44.7%   
Fx inflow Rs m8,7503,904 224.1%   
Fx outflow Rs m1,8044,037 44.7%   
Net fx Rs m6,946-133 -5,232.3%   
CASH FLOW
From Operations Rs m2,3723,987 59.5%  
From Investments Rs m-6156,509 -9.4%  
From Financial Activity Rs m-1,358-15,827 8.6%  
Net Cashflow Rs m403-5,331 -7.6%  

Share Holding

Indian Promoters % 32.8 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 29.1 28.8 101.0%  
FIIs % 22.7 6.3 359.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 67.2 39.6 169.7%  
Shareholders   27,723 62,870 44.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NEULAND LABS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NEULAND LABS vs Sanofi India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NEULAND LABS vs Sanofi India Share Price Performance

Period NEULAND LABS Sanofi India S&P BSE HEALTHCARE
1-Day -1.12% 2.06% 1.18%
1-Month -11.56% -8.09% -0.75%
1-Year 269.91% 44.45% 61.82%
3-Year CAGR 43.81% 0.97% 18.16%
5-Year CAGR 59.26% 7.07% 19.79%

* Compound Annual Growth Rate

Here are more details on the NEULAND LABS share price and the Sanofi India share price.

Moving on to shareholding structures...

The promoters of NEULAND LABS hold a 32.8% stake in the company. In case of Sanofi India the stake stands at 60.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NEULAND LABS and the shareholding pattern of Sanofi India.

Finally, a word on dividends...

In the most recent financial year, NEULAND LABS paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 7.8%.

Sanofi India paid Rs 570.0, and its dividend payout ratio stood at 211.5%.

You may visit here to review the dividend history of NEULAND LABS, and the dividend history of Sanofi India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.